Ashish Kamat, Associated Editor at European Urology Oncology, shared on LinkedIn:
“Always a pleasure chatting with Rick Bangs! Hard to believe this is my 5th appearance!
This time, we discuss a particularly timely topic: bladder preservation after systemic therapy for MIBC.
With the impressive responses we’re seeing from newer regimens, the opportunities are exciting, but important questions remain about who can safely avoid cystectomy.”
You can also read:
CA017-078 Trial: Does Perioperative Nivolumab Add Benefit in MIBC?
